-
Something wrong with this record ?
A study of a novel coprocessed dry binder composed of α-lactose monohydrate, microcrystalline cellulose and corn starch
J. Mužíková, A. Srbová, P. Svačinová,
Language English Country England, Great Britain
Document type Journal Article
- MeSH
- Cellulose MeSH
- Technology, Pharmaceutical * MeSH
- Zea mays * MeSH
- Lactose MeSH
- Tensile Strength MeSH
- Excipients MeSH
- Starch MeSH
- Tablets MeSH
- Publication type
- Journal Article MeSH
This paper deals with a study of the novel coprocessed dry binder Combilac®, which contains 70% of α-lactose monohydrate, 20% of microcrystalline cellulose and 10% of native corn starch. These tests include flow properties, compressibility, lubricant sensitivity, tensile strength and disintegration time of tablets. Compressibility is evaluated by means of the energy profile of compression process, test of stress relaxation and tablet strength. The above-mentioned parameters are also evaluated in the physical mixture of α-lactose monohydrate, microcrystalline cellulose and native corn starch and compared with Combilac. Combilac shows much better flowability than the physical mixture of the used dry binders. Its compressibility is better, tablets possess a higher tensile strength. Neither Combilac, nor the physical mixture can be compressed without lubricants due to high friction and sticking to the matrix. Combilac has a higher lubricant sensitivity than the physical mixture of the dry binders. Disintegration time of Combilac tablets is comparable with the disintegration time of tablets made from the physical mixture.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18025398
- 003
- CZ-PrNML
- 005
- 20180718101840.0
- 007
- ta
- 008
- 180709s2017 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3109/10837450.2015.1131717 $2 doi
- 035 __
- $a (PubMed)26758475
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Mužíková, Jitka $u a Department of Pharmaceutical Technology , Charles University in Prague, Faculty of Pharmacy in Hradec Králové , Czech Republic.
- 245 12
- $a A study of a novel coprocessed dry binder composed of α-lactose monohydrate, microcrystalline cellulose and corn starch / $c J. Mužíková, A. Srbová, P. Svačinová,
- 520 9_
- $a This paper deals with a study of the novel coprocessed dry binder Combilac®, which contains 70% of α-lactose monohydrate, 20% of microcrystalline cellulose and 10% of native corn starch. These tests include flow properties, compressibility, lubricant sensitivity, tensile strength and disintegration time of tablets. Compressibility is evaluated by means of the energy profile of compression process, test of stress relaxation and tablet strength. The above-mentioned parameters are also evaluated in the physical mixture of α-lactose monohydrate, microcrystalline cellulose and native corn starch and compared with Combilac. Combilac shows much better flowability than the physical mixture of the used dry binders. Its compressibility is better, tablets possess a higher tensile strength. Neither Combilac, nor the physical mixture can be compressed without lubricants due to high friction and sticking to the matrix. Combilac has a higher lubricant sensitivity than the physical mixture of the dry binders. Disintegration time of Combilac tablets is comparable with the disintegration time of tablets made from the physical mixture.
- 650 _2
- $a celulosa $7 D002482
- 650 _2
- $a pomocné látky $7 D005079
- 650 _2
- $a laktosa $7 D007785
- 650 _2
- $a škrob $7 D013213
- 650 _2
- $a tablety $7 D013607
- 650 12
- $a farmaceutická technologie $7 D013678
- 650 _2
- $a pevnost v tahu $7 D013718
- 650 12
- $a kukuřice setá $7 D003313
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Srbová, Alena $u a Department of Pharmaceutical Technology , Charles University in Prague, Faculty of Pharmacy in Hradec Králové , Czech Republic.
- 700 1_
- $a Svačinová, Petra $u a Department of Pharmaceutical Technology , Charles University in Prague, Faculty of Pharmacy in Hradec Králové , Czech Republic.
- 773 0_
- $w MED00004889 $t Pharmaceutical development and technology $x 1097-9867 $g Roč. 22, č. 8 (2017), s. 964-971
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/26758475 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20180709 $b ABA008
- 991 __
- $a 20180718102140 $b ABA008
- 999 __
- $a ok $b bmc $g 1317529 $s 1022319
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 22 $c 8 $d 964-971 $e 20160112 $i 1097-9867 $m Pharmaceutical development and technology $n Pharm Dev Technol $x MED00004889
- LZP __
- $a Pubmed-20180709